Literature DB >> 28063638

Functional Dissection of the m6A RNA Modification.

Brooke Huisman1, Gabriel Manske1, Stephen Carney1, Sundeep Kalantry2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28063638      PMCID： PMC5272839          DOI： 10.1016/j.tibs.2016.12.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN： 0968-0004            Impact factor:   13.807


× No keyword cloud information.
  19 in total

1.  Using the lambdaN peptide to tether proteins to RNAs.

Authors:  Julie Baron-Benhamou; Niels H Gehring; Andreas E Kulozik; Matthias W Hentze
Journal:  Methods Mol Biol       Date:  2004

Review 2.  Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression.

Authors:  Jesse M Engreitz; Noah Ollikainen; Mitchell Guttman
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-26       Impact factor: 94.444

3.  Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain.

Authors:  Chao Xu; Xiao Wang; Ke Liu; Ian A Roundtree; Wolfram Tempel; Yanjun Li; Zhike Lu; Chuan He; Jinrong Min
Journal:  Nat Chem Biol       Date:  2014-09-21       Impact factor: 15.040

4.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

Review 5.  Long nonoding RNAs in the X-inactivation center.

Authors:  Emily Maclary; Michael Hinten; Clair Harris; Sundeep Kalantry
Journal:  Chromosome Res       Date:  2013-12       Impact factor: 5.239

6.  The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus.

Authors:  C J Brown; B D Hendrich; J L Rupert; R G Lafrenière; Y Xing; J Lawrence; H F Willard
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

7.  Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle.

Authors:  Keiko Horiuchi; Takeshi Kawamura; Hiroko Iwanari; Riuko Ohashi; Makoto Naito; Tatsuhiko Kodama; Takao Hamakubo
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

8.  RNA methylation by the MIS complex regulates a cell fate decision in yeast.

Authors:  Sudeep D Agarwala; Hannah G Blitzblau; Andreas Hochwagen; Gerald R Fink
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

9.  A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing.

Authors:  Benoit Moindrot; Andrea Cerase; Heather Coker; Osamu Masui; Anne Grijzenhout; Greta Pintacuda; Lothar Schermelleh; Tatyana B Nesterova; Neil Brockdorff
Journal:  Cell Rep       Date:  2015-07-16       Impact factor: 9.423

10.  The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3.

Authors:  Colleen A McHugh; Chun-Kan Chen; Amy Chow; Christine F Surka; Christina Tran; Patrick McDonel; Amy Pandya-Jones; Mario Blanco; Christina Burghard; Annie Moradian; Michael J Sweredoski; Alexander A Shishkin; Julia Su; Eric S Lander; Sonja Hess; Kathrin Plath; Mitchell Guttman
Journal:  Nature       Date:  2015-04-27       Impact factor: 49.962
View more
  9 in total

Review 1.  Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma.

Authors:  Feng Tang; Zhiyong Pan; Yi Wang; Tian Lan; Mengyue Wang; Fengping Li; Wei Quan; Zhenyuan Liu; Zefen Wang; Zhiqiang Li
Journal:  Neurosci Bull       Date:  2022-06-07       Impact factor: 5.271

2.  Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas.

Authors:  Shengchao Xu; Lu Tang; Gan Dai; Chengke Luo; Zhixiong Liu
Journal:  Front Cell Dev Biol       Date:  2020-11-10

3.  Unraveling the RNA modification code with mass spectrometry.

Authors:  Richard Lauman; Benjamin A Garcia
Journal:  Mol Omics       Date:  2020-04-14

4.  Gene Signatures and Prognostic Values of m6A Genes in Nasopharyngeal Carcinoma.

Authors:  Shanshan Lu; Zhengzheng Yu; Zhiqiang Xiao; Yiya Zhang
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

5.  Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1.

Authors:  Chaohui Gu; Zhiyu Wang; Naichun Zhou; Guanru Li; Yiping Kou; Yang Luo; Yidi Wang; Jinjian Yang; Fengyan Tian
Journal:  Mol Cancer       Date:  2019-11-25       Impact factor: 27.401

6.  Regulation of AR mRNA translation in response to acute AR pathway inhibition.

Authors:  Syam Prakash Somasekharan; Neetu Saxena; Fan Zhang; Eliana Beraldi; Jia Ni Huang; Christina Gentle; Ladan Fazli; Marisa Thi; Poul H Sorensen; Martin Gleave
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

Review 7.  Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.

Authors:  Mohammad Burhan Uddin; Zhishan Wang; Chengfeng Yang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

8.  Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation.

Authors:  Shu Xu; Ya Li; Ju-Ping Chen; Da-Zhuang Li; Qin Jiang; Ting Wu; Xiao-Zhong Zhou
Journal:  Cell Death Dis       Date:  2020-09-30       Impact factor: 8.469

9.  m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization.

Authors:  Chuandong Lang; Chi Yin; Kaiyuan Lin; Yue Li; Qing Yang; Zhengquan Wu; Hong Du; Dong Ren; Yuhu Dai; Xinsheng Peng
Journal:  Clin Transl Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.